A kind of dabigatran etexilate mesylate pellet and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 哈药集团股份有限公司
- Publication Date
- 2019-06-07
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to dabigatran etexilate mesylate pellets and a preparation method, belonging to the technical field of medicine. Background technique
[0002] With the aging of the population and the increase in the incidence of cardiovascular diseases, the current anticoagulant gold standard drugs can no longer adapt and meet these needs. It is an inevitable trend that successively improved new drugs are approved for marketing, so it is expected that the market structure of anticoagulant drugs will change.
[0003] What needs to be pointed out is that anticoagulation and antiplatelet therapy are different. Aspirin, clopidogrel, etc. are antiplatelet therapy, not anticoagulation. Both anticoagulation and antiplatelet therapy are antithrombotic treatments, but their specific mechanisms of action are different. In addition, anticoagulation therapy is generally stronger than antiplatelet therapy.
[0004] First, platelets play a very important rol...